Assignee
SHANGHAI CUREGENE PHARMACEUTICAL CO LTD
CN·2 granted patents·3 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
5 records- 0161US11834413B2Antiplatelet drugs and uses thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2023·Granted Dec 5, 2023·0 cites·9 claims
- 0260US2025333382A1Antiplatelet drugs and uses thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0359US2025152571A1Pharmaceutical composition of antiplatelet drug, and use thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0458US2025312326A1Pharmaceutical composition of antiplatelet drug, and use thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0556US12410132B2Antiplatelet drugs and uses thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 9, 2025·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI CUREGENE PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →